SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-24-000198
Filing Date
2024-08-02
Accepted
2024-08-02 16:03:02
Documents
82
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrtx-20240630.htm   iXBRL 10-Q 1406588
2 EX-10.1 a2024q210-qexhibit101.htm EX-10.1 32158
3 EX-31.1 a2024q210-qexhibit311.htm EX-31.1 10731
4 EX-31.2 a2024q210-qexhibit312.htm EX-31.2 10729
5 EX-32.1 a2024q210-qexhibit321.htm EX-32.1 6302
11 GRAPHIC vrtx-20240630_g1.jpg GRAPHIC 41181
  Complete submission text file 0000875320-24-000198.txt   7933778

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20240630.xsd EX-101.SCH 45778
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20240630_cal.xml EX-101.CAL 90936
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20240630_def.xml EX-101.DEF 246980
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20240630_lab.xml EX-101.LAB 614342
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20240630_pre.xml EX-101.PRE 455810
85 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20240630_htm.xml XML 1312113
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 241170872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)